Literature DB >> 28243735

New insights into vitamin D anticancer properties: focus on miRNA modulation.

Katarina Zeljic1, Gordana Supic2,3, Zvonko Magic2,3.   

Abstract

Vitamin D anticancer properties are well known and have been demonstrated in many in vitro and in vivo studies. Mechanistic insights have given an explanation on how vitamin D exerts antineoplastic functions, which are mainly conducted via the canonical vitamin D receptor (VDR)-vitamin D response elements (VDRE) pathway. Numerous findings indicate that dietary components, including vitamin D, could exert chemopreventive effects through alterations of microRNA (miRNA) expression. As miRNAs have important roles in regulating diverse and vital cellular processes, it has been speculated that vitamin D's non-classical effects, including anticancer effects, could be mediated through alterations of miRNA expression level. The current review focuses on up-to-date experimental data on modulation of miRNA expression by vitamin D treatment in cancer, obtained in a cell culture system, animal models and human cohorts. Reported findings in the review show that vitamin D modulates expression of numerous and diverse miRNAs specific for cancer types. Even in its early phases, with many questions remaining to be answered, dissecting the molecular pathways of vitamin D miRNA modulation is an emerging area of science. The complete unraveling of vitamin D molecular mechanisms will emphasize the vitamin D dietary component as a potential chemopreventive agent in cancer and personalized nutrition.

Entities:  

Keywords:  Cancer; Vitamin D; miRNA

Mesh:

Substances:

Year:  2017        PMID: 28243735     DOI: 10.1007/s00438-017-1301-9

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  81 in total

1.  Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment.

Authors:  Liang Zhang; Nicole Stokes; Lisa Polak; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

2.  Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation.

Authors:  Mark Lutherborrow; Adam Bryant; Vivek Jayaswal; David Agapiou; Catalina Palma; Yee Hwa Yang; David D F Ma
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

3.  Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells.

Authors:  Ramiro José González-Duarte; Verna Cázares-Ordoñez; Sandra Romero-Córdoba; Lorenza Díaz; Víctor Ortíz; Julio Augusto Freyre-González; Alfredo Hidalgo-Miranda; Fernando Larrea; Euclides Avila
Journal:  Biochem Cell Biol       Date:  2015-05-20       Impact factor: 3.626

4.  VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.

Authors:  S Essa; N Denzer; U Mahlknecht; R Klein; E M Collnot; W Tilgen; J Reichrath
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-11       Impact factor: 4.292

5.  Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.

Authors:  Robert Borkowski; Liqin Du; Zhenze Zhao; Elizabeth McMillan; Adam Kosti; Chin-Rang Yang; Milind Suraokar; Ignacio I Wistuba; Adi F Gazdar; John D Minna; Michael A White; Alexander Pertsemlidis
Journal:  Cancer Res       Date:  2014-12-17       Impact factor: 12.701

Review 6.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

7.  MicroRNA regulates human vitamin D receptor.

Authors:  Takuya Mohri; Miki Nakajima; Shingo Takagi; Sayaka Komagata; Tsuyoshi Yokoi
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

8.  1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells.

Authors:  Shanwen Chen; Jing Zhu; Shuai Zuo; Ju Ma; Junling Zhang; Guowei Chen; Xin Wang; Yisheng Pan; Yucun Liu; Pengyuan Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-10-30       Impact factor: 3.575

9.  Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.

Authors:  Hun Ju Lee; Josephia R Muindi; Wei Tan; Qiang Hu; Dan Wang; Song Liu; Gregory E Wilding; Laurie A Ford; Sheila N J Sait; Annemarie W Block; Araba A Adjei; Maurice Barcos; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Candace S Johnson; Donald L Trump; Meir Wetzler
Journal:  Cancer       Date:  2013-10-25       Impact factor: 6.860

10.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

Authors:  H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  10 in total

1.  [Vitamin D down-regulates microRNA-21 expression to promote human placental trophoblast cell migration and invasion in vitro].

Authors:  Zhiyi Zhou; Xiaojuan Li; Guoqing Jiang; Jue Wang; Yuan Qian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

Review 2.  Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells.

Authors:  Mariarosaria Negri; Annalisa Gentile; Cristina de Angelis; Tatiana Montò; Roberta Patalano; Annamaria Colao; Rosario Pivonello; Claudia Pivonello
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

Review 3.  Prenatal epigenetics diets play protective roles against environmental pollution.

Authors:  Shizhao Li; Min Chen; Yuanyuan Li; Trygve O Tollefsbol
Journal:  Clin Epigenetics       Date:  2019-05-16       Impact factor: 6.551

4.  Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit.

Authors:  Donatella Paola Provvisiero; Mariarosaria Negri; Cristina de Angelis; Gilda Di Gennaro; Roberta Patalano; Chiara Simeoli; Fortuna Papa; Rosario Ferrigno; Renata Simona Auriemma; Maria Cristina De Martino; Annamaria Colao; Rosario Pivonello; Claudia Pivonello
Journal:  Sci Rep       Date:  2019-08-12       Impact factor: 4.379

Review 5.  Vitamin D and Its Target Genes.

Authors:  Carsten Carlberg
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

6.  Challenges of Differential Diagnosis Between Primary Hyperparathyroidism and Bone Metastases of Breast Cancer.

Authors:  Maksym Gorobeiko; Andrii Dinets; Denys Pominchuk; Karim Abdalla; Yuriy Prylutskyy; Viktoria Hoperia
Journal:  Clin Med Insights Case Rep       Date:  2022-09-20

Review 7.  Nutrimiromics: Role of microRNAs and Nutrition in Modulating Inflammation and Chronic Diseases.

Authors:  Bruna J Quintanilha; Bruna Z Reis; Graziela B Silva Duarte; Silvia M F Cozzolino; Marcelo M Rogero
Journal:  Nutrients       Date:  2017-10-27       Impact factor: 5.717

8.  Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.

Authors:  Xiaolai Hou; Fenlan Xu; Cheng Zhang; Jianzhong Shuai; Zhenhua Huang; Yu Liang; Xiaoyan Xu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 9.  Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.

Authors:  Kyriacos Felekkis; Christos Papaneophytou
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

Review 10.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.